Note: Ingredients listed on restricted chemical lists
EC/CAS
200-002-3/50-01-1
Name of the chemical
Guanidinium chloride
Concentration
>=50,0-<
General Information
Revision date
2021-08-16
Product name
AVENIO CFDNA ISOLATION KIT V2
Emergency telephone
+44 1444 256500, +44 1444 256561, +44 344 892 0111, +44 845 4647, +44 7710 - 391653
Icons in SDS
Company Information
company name
Roche Diagnostics Limited
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H302+H332, H315, H317, H319, H334, H335, H411
Hazard statements
Code
Statements
H302+H332
Harmful if swallowed or if inhaled
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
The product is a kit consisting of individual ingredients. The classification of the ingredients can be obtained from section 3. Section Label elements contains the resulting labelling for the kit.
Signal word
Danger
Hazard statements
H302 + H332 Harmful if swallowed or if inhaled. H315 Causes skin irritation. H317 May cause an allergic skin reaction. H319 Causes serious eye irritation. H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled. H335 May cause respiratory irritation. H411 Toxic to aquatic life with long lasting effects.
Prevention
P261 Avoid breathing mist or vapours. P273 Avoid release to the environment. P280 Wear protective gloves/ eye protection/ face protection.
Response
P304 + P340 + P312 IF INHALED: Remove person to fresh air and keep comfortable for breathing. Call a POISON CENTER/ doctor if you feel unwell. P342 + P311 If experiencing respiratory symptoms: Call a POISON CENTER/ doctor. P391 Collect spillage.
ECOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regu- lation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
TOXICOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
